Pharma News

India on Track for Dengue Vaccine by 2026

India could see a medlinkdengue vaccine/medlink (!--ref1--) by

NSAIDs for High-Risk Groups Could Cost NHS 31 Million Over 10 Years

Prescribing non-steroidal anti-inflammatory drugs (

Prescription Surge: GLP-1RAs for Obesity Without Type 2 Diabetes on the Rise

A nationwide study revealed a significant rise in new

Nirmatrelvir/Ritonavir May Reduce COVID-19 Hospitalizations

SARS-CoV-2, the virus behind the medlinkCOVID-19 pandemic/

Introducing Tirzepatide in India: A New Era in Diabetes Care

Recently, the Central Drugs Standard Control Organisation (CDSCO) in

Turning Back Time: Breakthrough Anti-aging Drug Extends Lifespan by 25%

The pursuit of a longer life has long

Mushroom Gummies May Contain Illegal Hallucinogens

Experts from UVA Health are issuing a

How Doxorubicin, the Top Chemotherapy Drug, Can Lead to Heart Damage

There's still much to learn about how doxorubicin, a 50-year-old

India Braces for Obesity Pill Revolution as Patents Near Expiry

According to the latest study by the Indian Council of Medical Research-India

Over 1.6 Million Indian Children Missed Vital Vaccinations in 2023

India's medlinkchild immunization/medlink levels, three

Nanoparticle Vaccines Boost Influenza Protection

Nanoparticle vaccines can generate crucial

Enhanced Fertility Outcomes With OXO-001 in IVF

New research has demonstrated the

High Aspirin Use Among Older Adults Despite Risks

A survey of approximately 150 million adults annually indicates

Weight Changes Caused by Common Antidepressant Medications

Recent findings comparing weight gain among eight

Potential Tuberculosis Vaccine for All Ages Discovered

medlinkTuberculosis/medlink (TB) remains the leading

FDA Awards Record mRNA Vaccine Review in 2023

The success of medlinkCOVID-19/medlink mRNA

Major Opioid Prescriptions Stem From Select Surgical Procedures

Several routine surgical procedures dominate the

Microrobot Pill Promising for Treating Inflammatory Bowel Disease

Researchers have created an

Prolonged-Release Ketamine Tablets: Potential Cure for Severe Depression

A novel tablet formulation of ketamine has

Clicking for Health: Social Media Spurs Vaccination Frequency

Scholars and journalists have expressed concerns that social media could

Tirzepatide Treats Obesity Even in Diabetics and Those With Other Complications

The presence of medical conditions associated with obesity does not affect

GLP-1 Drugs for Diabetes and Obesity: May Reduce Risk of Acute Pancreatitis

A recent study showed that the medicines Glucagon-like peptide-

Stomach Paralysis Risk Found in Users of Weight Loss Drugs

In a concerning revelation, the utilization of popular diabetes and weight loss

Semaglutide's Multifaceted Benefits in Diabetes Treatment

medlinkSemaglutide/medlink, as highlighted by

From Pandemic to Poultry: COVID Shot Tech Targets H5N1 Bird Flu

In response to the worldwide surge in H5N1 cases, American researchers have

Diabetes and Obesity Market of GLP-1 Drugs Will Be (Dollor) 125 Billion By 2033!

The medlinktype 2 diabetes/medlink and obesity

Blood Pressure Drugs Double Bone-Fracture Risk

medlinkBlood pressure/medlink medications

Generic Dexamethasone Tablets: USFDA Approval to Zydus for Arthritis

Zydus Lifesciences, an Indian pharmaceutical company, revealed on

Safety of Rotavirus Vaccinations in NICU Babies

Providing medlinkrotavirus vaccine/medlink to medlinkinfants/medlink

Dapagliflozin: A Potential Aid in Acute Heart Failure

Dapagliflozin, a medication prescribed for managing medlinkType

Harnessing mRNA Vaccine Technology for Disease Prevention

The efficacy of mRNA vaccine technology demonstrated during

Lower Dose MPox Vaccine: Safe With Equal Six-Week Antibody Response

An intradermal medlinkmonkeypox/

Cholera Oral Vaccine: WHO Prequalifies a New Simplified Vaccine

The World Health Organization (WHO) granted

Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA

Alectinib, a

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The medlinkimmunotherapy-boosting drug/medlink N-803, with the brand name

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Biopharmaceutical companies are once again competing in

Semaglutide: A Dominant Player for Patients With Heart Failure

A study was presented by the Gardy Health system in

Physician's Lack Agreement - Patients Prefer Branded or Generic Drugs?

Generic drugs and Branded drugs are essentially the same, as they

Drug Resistant Melanoma Caused Due to Break in Genes!

Melanoma is an

Marijuana Use for Morning Sickness Risks Mother and Baby Health

Using marijuana to alleviate medlinknausea and

Antibiotics Ineffective for Many Lower Tract Respiratory Infections

A comprehensive study reveals that the

No Acetaminophen-Pregnancy Link to Autism, ADHD, or Intellectual Disability

Researchers have discovered no substantiated evidence

Predicting Weight Gain With Antipsychotic Medication

Development and predictors of clinically significant

Nasal Spray's Potential in Treating Sleep Apnea

Bedtime nasal spray shows promise in alleviating sleep apnea

First Recombinant Vaccine for Swine Fever Virus

Researchers at the Indian Institute of Technology (IIT) Guwahati disclosed

Birth Control Pill Opill to be Available Over the Counter in USA

Perrigo's announcement of Opill (

Ozempic and Wegovy - GLP-1 Agonists Set to Become the Best-selling Drugs in 2024

The rise of GLP-1 agonist drugs, including Ozempic and Wegovy, has

Can This New Drug Cure Ebola by Targeting Replication?

Ebola virus disease (EVD), caused by several species of viruses belonging

Accelerated FDA Approval of Resmetirom for the Treatment of MASH/NASH

On March 14, 2024, the FDA announced its accelerated approval

The Risks of Self-Prescribed Vitamin Supplements

While vitamin pills can benefit individuals